TreeWAS – Variant ID: rs13224682

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G62.9 Polyneuropathy, unspecified	0.013	0.987	0.000
Z09.9 Follow-up examination after unspecified treatment for other conditions	0.000	0.989	0.011
H43.8 Other disorders of vitreous body	0.000	0.990	0.010
K35.9 Acute appendicitis, unspecified	0.000	0.991	0.009
G62 Other polyneuropathies	0.008	0.991	0.000
S02.60 Fracture of mandible (closed)	0.000	0.992	0.008
M25.57 Pain in joint (Ankle and foot)	0.008	0.992	0.000
H43 Disorders of vitreous body	0.000	0.992	0.008
S02.6 Fracture of mandible	0.000	0.993	0.007
G62.0 Drug-induced polyneuropathy	0.007	0.993	0.000
G62.1 Alcoholic polyneuropathy	0.007	0.993	0.000
H43.1 Vitreous haemorrhage	0.000	0.993	0.007
H43.9 Disorder of vitreous body, unspecified	0.000	0.993	0.006
G62.2 Polyneuropathy due to other toxic agents	0.006	0.994	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.994	0.006
H43.2 Crystalline deposits in vitreous body	0.000	0.994	0.006
H43.3 Other vitreous opacities	0.000	0.994	0.006
S02.2 Fracture of nasal bones	0.000	0.994	0.006
S02 Fracture of skull and facial bones	0.000	0.994	0.006
H43.0 Vitreous prolapse	0.000	0.994	0.006
S02.8 Fractures of other skull and facial bones	0.000	0.994	0.006
G60 Hereditary and idiopathic neuropathy	0.006	0.994	0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.006	0.994	0.000
Z00.0 General medical examination	0.005	0.995	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.995	0.005
S02.61 Fracture of mandible (open)	0.000	0.995	0.005
K80.1 Calculus of gallbladder with other cholecystitis	0.005	0.995	0.000
S02.0 Fracture of vault of skull	0.000	0.995	0.005
G60.0 Hereditary motor and sensory neuropathy	0.005	0.995	0.000
G60.8 Other hereditary and idiopathic neuropathies	0.005	0.995	0.000
S02.00 Fracture of vault of skull (closed)	0.000	0.995	0.005
S02.21 Fracture of nasal bones (open)	0.000	0.995	0.005
H43-H45 Disorders of vitreous body and globe	0.000	0.995	0.005
S02.4 Fracture of malar and maxillary bones	0.000	0.995	0.005
S02.7 Multiple fractures involving skull and facial bones	0.000	0.996	0.004
S02.1 Fracture of base of skull	0.000	0.996	0.004
S02.5 Fracture of tooth	0.000	0.996	0.004
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.004	0.996	0.000
H44 Disorders of globe	0.000	0.996	0.004
G60.9 Hereditary and idiopathic neuropathy, unspecified	0.004	0.996	0.000
G64 Other disorders of peripheral nervous system	0.004	0.996	0.000
S02.81 Fractures of other skull and facial bones (open)	0.000	0.996	0.004
G60.3 Idiopathic progressive neuropathy	0.004	0.996	0.000
G60.2 Neuropathy in association with hereditary ataxia	0.004	0.996	0.000
G60.1 Refsum's disease	0.004	0.996	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.996	0.004
S02.3 Fracture of orbital floor	0.000	0.996	0.004
G62.8 Other specified polyneuropathies	0.004	0.996	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.004	0.996	0.000
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.000	0.996	0.004
G63 Polyneuropathy in diseases classified elsewhere	0.004	0.996	0.000
S02.01 Fracture of vault of skull (open)	0.000	0.996	0.004
H44.2 Degenerative myopia	0.000	0.996	0.004
G40 Epilepsy	0.004	0.996	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.004	0.996	0.000
H44.5 Degenerated conditions of globe	0.000	0.996	0.004
C25.0 Head of pancreas	0.000	0.996	0.004
G40.9 Epilepsy, unspecified	0.004	0.996	0.000
G61 Inflammatory polyneuropathy	0.004	0.996	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.996	0.004
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.004	0.996	0.000
G91.9 Hydrocephalus, unspecified	0.004	0.996	0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.000	0.996	0.003
H44.4 Hypotony of eye	0.000	0.996	0.003
S02.10 Fracture of base of skull (closed)	0.000	0.996	0.003
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.997	0.003
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.003	0.997	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.997	0.003
S02.51 Fracture of tooth (open)	0.000	0.997	0.003
H44.1 Other endophthalmitis	0.000	0.997	0.003
M19.94 Arthrosis, unspecified (Hand)	0.000	0.997	0.003
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.997	0.003
H44.6 Retained (old) intraocular foreign body, magnetic	0.000	0.997	0.003
H44.3 Other degenerative disorders of globe	0.000	0.997	0.003
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.997	0.003
S02.11 Fracture of base of skull (open)	0.000	0.997	0.003
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.000	0.997	0.003
S02.50 Fracture of tooth (closed)	0.000	0.997	0.003
H44.9 Disorder of globe, unspecified	0.000	0.997	0.003
S02.31 Fracture of orbital floor (open)	0.000	0.997	0.003
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.003	0.997	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.003	0.997	0.000
E89.0 Postprocedural hypothyroidism	0.000	0.997	0.003
G40.8 Other epilepsy	0.003	0.997	0.000
K81.0 Acute cholecystitis	0.003	0.997	0.000
G63.8 Polyneuropathy in other diseases classified elsewhere	0.003	0.997	0.000
G63.6 Polyneuropathy in other musculoskeletal disorders	0.003	0.997	0.000
G63.5 Polyneuropathy in systemic connective tissue disorders	0.003	0.997	0.000
G63.4 Polyneuropathy in nutritional deficiency	0.003	0.997	0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.003	0.997	0.000
G63.1 Polyneuropathy in neoplastic disease	0.003	0.997	0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
H44.8 Other disorders of globe	0.000	0.997	0.003
H44.0 Purulent endophthalmitis	0.000	0.997	0.003
G40.7 Petit mal, unspecified, without grand mal seizures	0.003	0.997	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.000	0.997	0.003
G40.5 Special epileptic syndromes	0.003	0.997	0.000
G61.1 Serum neuropathy	0.003	0.997	0.000
G61.9 Inflammatory polyneuropathy, unspecified	0.003	0.997	0.000
S61.1 Open wound of finger(s) with damage to nail	0.000	0.997	0.003
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.003	0.997	0.000
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere	0.000	0.997	0.003
H45.1 Endophthalmitis in diseases classified elsewhere	0.000	0.997	0.003
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
G63.2 Diabetic polyneuropathy	0.003	0.997	0.000
H45.0 Vitreous haemorrhage in diseases classified elsewhere	0.000	0.997	0.003
S02.30 Fracture of orbital floor (closed)	0.000	0.997	0.003
C25 Malignant neoplasm of pancreas	0.000	0.997	0.003
C25.1 Body of pancreas	0.000	0.997	0.003
G61.8 Other inflammatory polyneuropathies	0.002	0.997	0.000
M47.99 Spondylosis, unspecified (Site unspecified)	0.000	0.997	0.003
H53.8 Other visual disturbances	0.003	0.997	0.000
G61.0 Guillain-Barre syndrome	0.003	0.997	0.000
H01.0 Blepharitis	0.003	0.997	0.000
K22.7 Barrett's oesophagus	0.003	0.997	0.000
I08.0 Disorders of both mitral and aortic valves	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
M53.3 Sacrococcygeal disorders, not elsewhere classified	0.000	0.998	0.002
C25.9 Pancreas, unspecified	0.000	0.998	0.002
Q63.0 Accessory kidney	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y84.8 Other medical procedures	0.002	0.998	0.000
G91 Hydrocephalus	0.002	0.998	0.000
E89.2 Postprocedural hypoparathyroidism	0.000	0.998	0.002
J35.0 Chronic tonsillitis	0.000	0.998	0.002
C25.8 Overlapping lesion of pancreas	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
C25.3 Pancreatic duct	0.000	0.998	0.002
N89 Other noninflammatory disorders of vagina	0.002	0.998	0.000
C25.2 Tail of pancreas	0.000	0.998	0.002
C25.7 Other parts of pancreas	0.000	0.998	0.002
N89.9 Noninflammatory disorder of vagina, unspecified	0.002	0.998	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.998	0.002
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.002	0.998	0.000
Q63 Other congenital malformations of kidney	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
J18.0 Bronchopneumonia, unspecified	0.000	0.998	0.002
M53.39 Sacrococcygeal disorders, not elsewhere classified-Site uns	0.000	0.998	0.002
G91.1 Obstructive hydrocephalus	0.002	0.998	0.000
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Z00.4 General psychiatric examination, not elsewhere classified	0.002	0.998	0.000
G91.3 Posttraumatic hydrocephalus, unspecified	0.002	0.998	0.000
M53.37 Sacrococcygeal disorders, not elsewhere classified-Lumbosac	0.000	0.998	0.002
M53.36 Sacrococcygeal disorders, not elsewhere classified-Lumbar	0.000	0.998	0.002
M53.35 Sacrococcygeal disorders, not elsewhere classified-Thoracol	0.000	0.998	0.002
M53.34 Sacrococcygeal disorders, not elsewhere classified-Thoracic	0.000	0.998	0.002
M53.33 Sacrococcygeal disorders, not elsewhere classified-Cervicot	0.000	0.998	0.002
M53.32 Sacrococcygeal disorders, not elsewhere classified-Cervical	0.000	0.998	0.002
M53.31 Sacrococcygeal disorders, not elsewhere classified-Occipit-	0.000	0.998	0.002
M53.30 Sacrococcygeal disorders, not elsewhere classified-Mult sit	0.000	0.998	0.002
G91.8 Other hydrocephalus	0.002	0.998	0.000
N89.5 Stricture and atresia of vagina	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.998	0.000
C25.4 Endocrine pancreas	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
E89.4 Postprocedural ovarian failure	0.000	0.998	0.002
Q63.1 Lobulated, fused and horseshoe kidney	0.002	0.998	0.000
R07.2 Precordial pain	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
G91.0 Communicating hydrocephalus	0.002	0.998	0.000
I42.0 Dilated cardiomyopathy	0.002	0.998	0.000
Q89.2 Congenital malformations of other endocrine glands	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.000	0.998	0.002
Q65.8 Other congenital deformities of hip	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.002	0.998	0.000
E89.1 Postprocedural hypoinsulinaemia	0.000	0.998	0.002
G50.0 Trigeminal neuralgia	0.002	0.998	0.000
K80.8 Other cholelithiasis	0.002	0.998	0.000
N89.0 Mild vaginal dysplasia	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
G91.2 Normal-pressure hydrocephalus	0.002	0.998	0.000
N89.7 Haematocolpos	0.002	0.998	0.000
N89.4 Leukoplakia of vagina	0.002	0.998	0.000
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.002	0.998	0.000
Q60.0 Renal agenesis, unilateral	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Q89 Other congenital malformations, not elsewhere classified	0.002	0.998	0.000
N89.3 Dysplasia of vagina, unspecified	0.002	0.998	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.002	0.998	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
C18.7 Sigmoid colon	0.000	0.998	0.002
E83.3 Disorders of phosphorus metabolism	0.002	0.998	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.000	0.998	0.002
Q63.8 Other specified congenital malformations of kidney	0.002	0.998	0.000
Z00.3 Examination for adolescent development state	0.002	0.998	0.000
Z00.2 Examination for period of rapid growth in childhood	0.002	0.998	0.000
Z00.1 Routine child health examination	0.002	0.998	0.000
E89.5 Postprocedural testicular hypofunction	0.000	0.998	0.002
Q63.9 Congenital malformation of kidney, unspecified	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
Q63.3 Hyperplastic and giant kidney	0.002	0.998	0.000
Z00.8 Other general examinations	0.002	0.998	0.000
Q60-Q64 Congenital malformations of the urinary system	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
T90.5 Sequelae of intracranial injury	0.002	0.998	0.000
K80 Cholelithiasis	0.002	0.998	0.000
G45.4 Transient global amnesia	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
Q83 Congenital malformations of breast	0.002	0.998	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.000	0.998	0.002
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.998	0.002
E89.3 Postprocedural hypopituitarism	0.000	0.998	0.002
T36-T50 Poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.998	0.002
G30.9 Alzheimer's disease, unspecified	0.000	0.998	0.002
N89.1 Moderate vaginal dysplasia	0.002	0.998	0.000
Q80-Q89 Other congenital malformations	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
N89.6 Tight hymenal ring	0.002	0.998	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
Q63.2 Ectopic kidney	0.002	0.998	0.000
Q83.1 Accessory breast	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.002	0.998	0.000
T93.2 Sequelae of other fractures of lower limb	0.002	0.998	0.000
Q65 Congenital deformities of hip	0.002	0.998	0.000
T90 Sequelae of injuries of head	0.002	0.998	0.000
T90.9 Sequelae of unspecified injury of head	0.002	0.998	0.000
Q60.3 Renal hypoplasia, unilateral	0.002	0.998	0.000
Q89.0 Congenital malformations of spleen	0.002	0.998	0.000
Z00.5 Examination of potential donor of organ and tissue	0.002	0.998	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.002	0.998	0.000
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
Q60.2 Renal agenesis, unspecified	0.001	0.998	0.000
Q83.8 Other congenital malformations of breast	0.002	0.998	0.000
Q89.3 Situs inversus	0.001	0.998	0.000
T39.4 Antirheumatics, not elsewhere classified	0.002	0.998	0.000
T39.2 Pyrazolone derivatives	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
T47.7 Emetics	0.001	0.998	0.000
T47.5 Digestants	0.001	0.998	0.000
T47.3 Saline and osmotic laxatives	0.001	0.998	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
T93 Sequelae of injuries of lower limb	0.002	0.998	0.000
D36.7 Other specified sites	0.002	0.998	0.000
Q60.6 Potter's syndrome	0.001	0.998	0.000
Q60.5 Renal hypoplasia, unspecified	0.001	0.998	0.000
Q60.4 Renal hypoplasia, bilateral	0.001	0.998	0.000
Q60.1 Renal agenesis, bilateral	0.001	0.998	0.000
Q89.9 Congenital malformation, unspecified	0.001	0.998	0.000
Q89.8 Other specified congenital malformations	0.001	0.998	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.001	0.998	0.000
Q89.4 Conjoined twins	0.001	0.998	0.000
Q89.1 Congenital malformations of adrenal gland	0.001	0.998	0.000
Q85 Phakomatoses, not elsewhere classified	0.002	0.998	0.000
I08.2 Disorders of both aortic and tricuspid valves	0.002	0.998	0.000
Z00.6 Examination for normal comparison and control in clinical research programme	0.001	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.998	0.000
D07.4 Penis	0.000	0.998	0.002
D32.9 Meninges, unspecified	0.002	0.998	0.000
K80.4 Calculus of bile duct with cholecystitis	0.002	0.998	0.000
Q83.3 Accessory nipple	0.001	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.001	0.998	0.000
T90.0 Sequelae of superficial injury of head	0.001	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.001	0.998	0.000
H16.0 Corneal ulcer	0.002	0.998	0.000
K80.3 Calculus of bile duct with cholangitis	0.001	0.998	0.000
Q65.2 Congenital dislocation of hip, unspecified	0.001	0.998	0.000
T90.3 Sequelae of injury of cranial nerves	0.001	0.998	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.002	0.998	0.000
Q80 Congenital ichthyosis	0.001	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.002	0.998	0.000
K51.9 Ulcerative colitis, unspecified	0.002	0.998	0.000
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.001	0.998	0.000
Q62.5 Duplication of ureter	0.001	0.998	0.000
Q83.9 Congenital malformation of breast, unspecified	0.001	0.998	0.000
Q83.2 Absent nipple	0.001	0.998	0.000
Q83.0 Congenital absence of breast with absent nipple	0.001	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.001	0.998	0.000
T90.8 Sequelae of other specified injuries of head	0.001	0.998	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.001	0.998	0.000
I22.0 Subsequent myocardial infarction of anterior wall	0.002	0.998	0.000
N85.8 Other specified noninflammatory disorders of uterus	0.000	0.998	0.002
Q65.9 Congenital deformity of hip, unspecified	0.001	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.001	0.998	0.000
T90.1 Sequelae of open wound of head	0.001	0.998	0.000
Q64 Other congenital malformations of urinary system	0.001	0.998	0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.001	0.998	0.000
Q84 Other congenital malformations of integument	0.001	0.998	0.000
Q81 Epidermolysis bullosa	0.001	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.001	0.998	0.000
H16.9 Keratitis, unspecified	0.001	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.001	0.998	0.000
Q82 Other congenital malformations of skin	0.001	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.001	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.001	0.998	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.002	0.998	0.000
N94.1 Dyspareunia	0.000	0.998	0.002
Q50.5 Embryonic cyst of broad ligament	0.001	0.998	0.000
Q53.1 Undescended testicle, unilateral	0.001	0.998	0.000
Q65.6 Unstable hip	0.001	0.998	0.000
Q65.5 Congenital subluxation of hip, unspecified	0.001	0.998	0.000
Q65.4 Congenital subluxation of hip, bilateral	0.001	0.998	0.000
Q65.3 Congenital subluxation of hip, unilateral	0.001	0.998	0.000
Q65.1 Congenital dislocation of hip, bilateral	0.001	0.998	0.000
Q65.0 Congenital dislocation of hip, unilateral	0.001	0.998	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.001	0.998	0.000
N85.0 Endometrial glandular hyperplasia	0.000	0.998	0.001
S29.9 Unspecified injury of thorax	0.000	0.998	0.001
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.001	0.998	0.000
Q50-Q56 Congenital malformations of genital organs	0.001	0.998	0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.001	0.999	0.000
Q82.8 Other specified congenital malformations of skin	0.001	0.999	0.000
T48.5 Anti-common-cold drugs	0.001	0.999	0.000
Q53 Undescended testicle	0.001	0.999	0.000
S22.50 Flail chest (closed)	0.000	0.999	0.001
D05.0 Lobular carcinoma in situ	0.000	0.999	0.001
K80.0 Calculus of gallbladder with acute cholecystitis	0.001	0.999	0.000
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.001	0.999	0.000
Q62.8 Other congenital malformations of ureter	0.001	0.999	0.000
Q62.7 Congenital vesico-uretero-renal reflux	0.001	0.999	0.000
Q62.6 Malposition of ureter	0.001	0.999	0.000
Q62.4 Agenesis of ureter	0.001	0.999	0.000
Q62.2 Congenital megaloureter	0.001	0.999	0.000
Q62.1 Atresia and stenosis of ureter	0.001	0.999	0.000
Q62.0 Congenital hydronephrosis	0.001	0.999	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.999	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.999	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.999	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.001	0.999	0.000
T44.0 Anticholinesterase agents	0.001	0.999	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.001	0.999	0.000
I08 Multiple valve diseases	0.001	0.999	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.001	0.999	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.999	0.001
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.001	0.999	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.001	0.999	0.000
Q85.1 Tuberous sclerosis	0.001	0.999	0.000
T41.2 Other and unspecified general anaesthetics	0.001	0.999	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.001	0.999	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.001	0.999	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.000	0.999	0.001
K85.1 Biliary acute pancreatitis	0.001	0.999	0.000
M47.9 Spondylosis, unspecified	0.000	0.999	0.001
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.001	0.999	0.000
Q50.0 Congenital absence of ovary	0.001	0.999	0.000
Q62.3 Other obstructive defects of renal pelvis and ureter	0.001	0.999	0.000
Q80.9 Congenital ichthyosis, unspecified	0.001	0.999	0.000
Q98.4 Klinefelter's syndrome, unspecified	0.001	0.999	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.999	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.999	0.000
T48.4 Expectorants	0.001	0.999	0.000
T48.3 Antitussives	0.001	0.999	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.001	0.999	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.999	0.000
T48.0 Oxytocic drugs	0.001	0.999	0.000
Q64.7 Other congenital malformations of bladder and urethra	0.001	0.999	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.999	0.000
T41.5 Therapeutic gases	0.001	0.999	0.000
T41.4 Anaesthetic, unspecified	0.001	0.999	0.000
T41.3 Local anaesthetics	0.001	0.999	0.000
T41.1 Intravenous anaesthetics	0.001	0.999	0.000
T41.0 Inhaled anaesthetics	0.001	0.999	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.001	0.999	0.000
Q52 Other congenital malformations of female genitalia	0.001	0.999	0.000
Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified	0.001	0.999	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.001	0.999	0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.001	0.999	0.000
M47.92 Spondylosis, unspecified (Cervical region)	0.000	0.999	0.001
D07.0 Endometrium	0.000	0.999	0.001
K51.3 Ulcerative (chronic) rectosigmoiditis	0.001	0.999	0.000
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.001	0.999	0.000
Q80.8 Other congenital ichthyosis	0.001	0.999	0.000
Q80.4 Harlequin foetus	0.001	0.999	0.000
Q80.3 Congenital bullous ichthyosiform erythroderma	0.001	0.999	0.000
Q80.2 Lamellar ichthyosis	0.001	0.999	0.000
Q80.1 X-linked ichthyosis	0.001	0.999	0.000
Q80.0 Ichthyosis vulgaris	0.001	0.999	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.000	0.999	0.001
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.001	0.999	0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.001	0.999	0.000
Q50.3 Other congenital malformations of ovary	0.001	0.999	0.000
Q50.2 Congenital torsion of ovary	0.001	0.999	0.000
Q50.1 Developmental ovarian cyst	0.001	0.999	0.000
Q64.9 Congenital malformation of urinary system, unspecified	0.001	0.999	0.000
Q64.8 Other specified congenital malformations of urinary system	0.001	0.999	0.000
Q64.6 Congenital diverticulum of bladder	0.001	0.999	0.000
Q64.5 Congenital absence of bladder and urethra	0.001	0.999	0.000
Q64.4 Malformation of urachus	0.001	0.999	0.000
Q64.2 Congenital posterior urethral valves	0.001	0.999	0.000
Q64.1 Exstrophy of urinary bladder	0.001	0.999	0.000
Q64.0 Epispadias	0.001	0.999	0.000
Q85.8 Other phakomatoses, not elsewhere classified	0.001	0.999	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.999	0.000
T37.5 Antiviral drugs	0.001	0.999	0.000
T37.4 Anthelminthics	0.001	0.999	0.000
T37.3 Other antiprotozoal drugs	0.001	0.999	0.000
T37.1 Antimycobacterial drugs	0.001	0.999	0.000
T37.0 Sulphonamides	0.001	0.999	0.000
H16 Keratitis	0.001	0.999	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.999	0.000
T36 Poisoning by systemic antibiotics	0.001	0.999	0.000
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M47.96 Spondylosis, unspecified (Lumbar region)	0.000	0.999	0.001
D07.2 Vagina	0.000	0.999	0.001
H16.1 Other superficial keratitis without conjunctivitis	0.001	0.999	0.000
Q81.9 Epidermolysis bullosa, unspecified	0.001	0.999	0.000
Q81.8 Other epidermolysis bullosa	0.001	0.999	0.000
Q81.2 Epidermolysis bullosa dystrophica	0.001	0.999	0.000
Q81.1 Epidermolysis bullosa letalis	0.001	0.999	0.000
Q81.0 Epidermolysis bullosa simplex	0.001	0.999	0.000
Q82.9 Congenital malformation of skin, unspecified	0.001	0.999	0.000
Q82.4 Ectodermal dysplasia (anhidrotic)	0.001	0.999	0.000
Q82.3 Incontinentia pigmenti	0.001	0.999	0.000
Q82.1 Xeroderma pigmentosum	0.001	0.999	0.000
Q84.9 Congenital malformation of integument, unspecified	0.001	0.999	0.000
Q84.8 Other specified congenital malformations of integument	0.001	0.999	0.000
Q84.6 Other congenital malformations of nails	0.001	0.999	0.000
Q84.5 Enlarged and hypertrophic nails	0.001	0.999	0.000
Q84.4 Congenital leukonychia	0.001	0.999	0.000
Q84.3 Anonychia	0.001	0.999	0.000
Q84.2 Other congenital malformations of hair	0.001	0.999	0.000
Q84.1 Congenital morphological disturbances of hair, not elsewhere classified	0.001	0.999	0.000
Q84.0 Congenital alopecia	0.001	0.999	0.000
Q86.8 Other congenital malformation syndromes due to known exogenous causes	0.001	0.999	0.000
Q86.2 Dysmorphism due to warfarin	0.001	0.999	0.000
Q86.1 Foetal hydantoin syndrome	0.001	0.999	0.000
Q86.0 Foetal alcohol syndrome (dysmorphic)	0.001	0.999	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.001	0.999	0.000
T45.8 Other primarily systemic and haematological agents	0.001	0.999	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.999	0.000
T45.6 Fibrinolysis-affecting drugs	0.001	0.999	0.000
T45.4 Iron and its compounds	0.001	0.999	0.000
T45.3 Enzymes, not elsewhere classified	0.001	0.999	0.000
T49.9 Topical agent, unspecified	0.001	0.999	0.000
T49.8 Other topical agents	0.001	0.999	0.000
T49.7 Dental drugs, topically applied	0.001	0.999	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.001	0.999	0.000
T49.5 Ophthalmological drugs and preparations	0.001	0.999	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.999	0.000
T49.3 Emollients, demulcents and protectants	0.001	0.999	0.000
T49.2 Local astringents and local detergents	0.001	0.999	0.000
T49.1 Antipruritics	0.001	0.999	0.000
Z09 Follow-up examination after treatment for conditions other than malignant neoplasms	0.000	0.999	0.001
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.001	0.999	0.000
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.001	0.999	0.000
Q53.2 Undescended testicle, bilateral	0.001	0.999	0.000
S22.0 Fracture of thoracic vertebra	0.000	0.999	0.001
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.999	0.000
Z09.4 Follow-up examination after treatment of fracture	0.000	0.999	0.001
Q56 Indeterminate sex and pseudohermaphroditism	0.001	0.999	0.000
Q30-Q34 Congenital malformations of the respiratory system	0.001	0.999	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.001	0.999	0.000
D06.9 Cervix, unspecified	0.000	0.999	0.001
I22.1 Subsequent myocardial infarction of inferior wall	0.001	0.999	0.000
Q45.8 Other specified congenital malformations of digestive system	0.001	0.999	0.000
Q53.0 Ectopic testis	0.001	0.999	0.000
Q82.2 Mastocytosis	0.001	0.999	0.000
Q82.0 Hereditary lymphoedema	0.001	0.999	0.000
S89.9 Unspecified injury of lower leg	0.000	0.999	0.001
Q45 Other congenital malformations of digestive system	0.001	0.999	0.000
Q55 Other congenital malformations of male genital organs	0.001	0.999	0.000
Q51 Congenital malformations of uterus and cervix	0.001	0.999	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.001	0.999	0.000
D07.1 Vulva	0.000	0.999	0.001
H16.2 Keratoconjunctivitis	0.001	0.999	0.000
K22.1 Ulcer of oesophagus	0.001	0.999	0.000
Q52.5 Fusion of labia	0.001	0.999	0.000
Q52.1 Doubling of vagina	0.001	0.999	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.999	0.000
T45.5 Anticoagulants	0.001	0.999	0.000
Q99 Other chromosome abnormalities, not elsewhere classified	0.001	0.999	0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.000	0.999	0.001
D04.3 Skin of other and unspecified parts of face	0.000	0.999	0.001
H16.4 Corneal neovascularisation	0.001	0.999	0.000
Q82.5 Congenital nonneoplastic naevus	0.001	0.999	0.000
Q85.9 Phakomatosis, unspecified	0.001	0.999	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.001	0.999	0.000
T45.2 Vitamins, not elsewhere classified	0.001	0.999	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.001	0.999	0.000
T93.0 Sequelae of open wound of lower limb	0.001	0.999	0.000
Q14 Congenital malformations of posterior segment of eye	0.001	0.999	0.000
Q30 Congenital malformations of nose	0.001	0.999	0.000
Q35-Q37 Cleft lip and cleft palate	0.001	0.999	0.000
H16.8 Other keratitis	0.001	0.999	0.000
J43.9 Emphysema, unspecified	0.000	0.999	0.001
Q51.4 Unicornate uterus	0.001	0.999	0.000
Q52.9 Congenital malformation of female genitalia, unspecified	0.001	0.999	0.000
Q52.8 Other specified congenital malformations of female genitalia	0.001	0.999	0.000
Q52.7 Other congenital malformations of vulva	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations